Thyrocare Technologies Limited

Thyrocare Technologies Limited (THYROCARE) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Healthcare Services›Healthcare Service Provider

thyrocare.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-02

Stock price
₹576.75
Market cap
9,319 Cr
Stock P/E
59.7
P/B
15.51
Dividend yield
1.6%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales148 Cr135 Cr154 Cr157 Cr177 Cr166 Cr187 Cr193 Cr217 Cr196 Cr224 Cr240 Cr
Operating expenses (approx.)110 Cr103 Cr120 Cr114 Cr129 Cr124 Cr129 Cr135 Cr145 Cr138 Cr149 Cr163 Cr
EBITDA38 Cr32 Cr34 Cr43 Cr48 Cr42 Cr58 Cr58 Cr71 Cr58 Cr75 Cr77 Cr
OPM %25.4%23.4%21.9%27.2%27.2%25.2%30.8%29.9%33.0%29.6%33.5%32.2%
Other income2 Cr3 Cr3 Cr4 Cr3 Cr4 Cr5 Cr5 Cr3 Cr5 Cr4 Cr4 Cr
Interest1 Cr1 Cr1 Cr0.99 Cr0.76 Cr0.60 Cr0.70 Cr0.78 Cr0.59 Cr-0.09 Cr2 Cr1 Cr
Depreciation11 Cr13 Cr13 Cr11 Cr13 Cr17 Cr14 Cr11 Cr12 Cr22 Cr14 Cr12 Cr
Profit before tax28 Cr20 Cr23 Cr34 Cr37 Cr28 Cr47 Cr50 Cr63 Cr35 Cr64 Cr68 Cr
Tax %28.1%26.0%25.0%28.6%-28.2%32.1%54.3%24.1%23.6%20.7%24.4%24.8%
Net profit20 Cr15 Cr17 Cr24 Cr47 Cr19 Cr22 Cr38 Cr48 Cr28 Cr49 Cr51 Cr
EPS (₹)₹3.84₹2.78₹3.54₹4.52₹4.99₹3.58₹4.17₹7.35₹9.05₹1.82₹2.99₹3.23

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019Mar 2020Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales403 Cr433 Cr495 Cr589 Cr527 Cr572 Cr687 Cr829 CrSign in for TTM
Operating expenses (approx.)249 Cr261 Cr323 Cr354 Cr407 Cr434 Cr497 Cr567 CrSign in for TTM
EBITDA154 Cr173 Cr171 Cr235 Cr120 Cr137 Cr190 Cr262 CrSign in for TTM
OPM %38.3%39.8%34.6%39.9%22.8%24.0%27.7%31.6%Sign in for TTM
Other income10 Cr8 Cr12 Cr29 Cr8 Cr9 Cr15 Cr17 CrSign in for TTM
Interest0.61 Cr2 Cr0.87 Cr2 Cr2 Cr4 Cr3 Cr3 CrSign in for TTM
Depreciation26 Cr32 Cr30 Cr34 Cr39 Cr47 Cr55 Cr59 CrSign in for TTM
Profit before tax138 Cr140 Cr152 Cr228 Cr89 Cr96 Cr145 Cr213 CrSign in for TTM
Tax %38.3%37.0%25.8%22.7%27.4%27.6%37.6%23.5%Sign in for TTM
Net profit85 Cr88 Cr113 Cr176 Cr64 Cr69 Cr91 Cr163 CrSign in for TTM
EPS (₹)₹15.95₹16.74₹21.41₹33.30₹12.16₹13.42₹17.13₹10.27Sign in for TTM
Dividend payout %———45.0%123.3%137.1%105.0%91.1%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019Mar 2020Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital53 Cr53 Cr53 Cr53 Cr53 Cr53 Cr53 Cr159 Cr
Reserves382 Cr314 Cr374 Cr474 Cr481 Cr474 Cr494 Cr426 Cr
Borrowings—————22 Cr——
Other liabilities40 Cr103 Cr119 Cr81 Cr98 Cr95 Cr146 Cr161 Cr
Total liabilities475 Cr469 Cr546 Cr608 Cr633 Cr644 Cr693 Cr747 Cr
Fixed assets (net)——129 Cr150 Cr157 Cr168 Cr149 Cr206 Cr
CWIP——8 Cr3 Cr2 Cr3 Cr14 Cr3 Cr
Investments——126 Cr159 Cr151 Cr162 Cr162 Cr177 Cr
Loans & advances——0.60 Cr0.06 Cr0 Cr0 Cr0 Cr0 Cr
Inventories——23 Cr25 Cr28 Cr48 Cr47 Cr48 Cr
Trade receivables——45 Cr93 Cr85 Cr43 Cr73 Cr74 Cr
Cash & bank——13 Cr14 Cr18 Cr9 Cr18 Cr38 Cr
Other assets475 Cr469 Cr201 Cr164 Cr192 Cr210 Cr231 Cr201 Cr
Total assets475 Cr469 Cr546 Cr608 Cr633 Cr644 Cr693 Cr747 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019Mar 2020Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———267 Cr129 Cr168 Cr191 Cr213 Cr
Cash from investing———-120 Cr-39 Cr-91 Cr-53 Cr-23 Cr
Cash from financing———-147 Cr-86 Cr-85 Cr-130 Cr-170 Cr
Net cash flow———0.43 Cr4 Cr-8 Cr8 Cr21 Cr
Free cash flow (OCF − Capex)———229 Cr86 Cr106 Cr146 Cr192 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019Mar 2020Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %31.9%38.8%35.9%43.7%17.0%18.2%27.1%36.8%
ROE %0.0%24.1%26.8%36.5%12.0%13.4%16.7%27.8%
Debtor days——335859283932
Inventory days——5254641059081
Days payable——56365989147109
Cash conversion cycle——29756444-194
Debt / equity———0.00—0.040.00270.0009
Current ratio——2.504.343.543.082.773.39
Net debt / EBITDA0.000.000.000.00-0.150.09-0.09-0.15

Compare with peers

Loading peers…